(NASDAQ: SENS) Senseonics Holdings's forecast annual revenue growth rate of 58.48% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.06%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.82%.
Senseonics Holdings's revenue in 2026 is $35,257,000.On average, 10 Wall Street analysts forecast SENS's revenue for 2026 to be $2,564,748,383, with the lowest SENS revenue forecast at $2,402,511,893, and the highest SENS revenue forecast at $2,710,485,539. On average, 10 Wall Street analysts forecast SENS's revenue for 2027 to be $4,067,733,290, with the lowest SENS revenue forecast at $3,402,831,013, and the highest SENS revenue forecast at $5,561,319,843.
In 2028, SENS is forecast to generate $5,945,608,130 in revenue, with the lowest revenue forecast at $4,941,028,423 and the highest revenue forecast at $6,928,049,491.